Global Drugs of Abuse Testing Market Will Reach USD 3.4 Billion By 2018: ResearchMoz.us

ResearchMoz include new market research report” Drugs of Abuse Testing Market (Sample Based Testing – Urine, Saliva and Hair Onsite and laboratory Testing) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” to its huge collection of research reports.

Browse PDF – Drugs of Abuse Testing Market – Global Drugs of Abuse Testing Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

The global drugs of abuse testing market is rapidly growing due to the rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. Globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse.is also supporting the growth of the drugs of abuse testing market.

View Full Report With Complete TOC at http://www.researchmoz.us/drugs-of-abuse-testing-market-sample-based-testing-urine-saliva-and-hair-onsite-and-laboratory-testing-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2018-report.html

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. This report forecasts future potential of all these drugs of abuse testing markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

The report categorizes the global drugs of abuse market based on their type and geography. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and is generally preferred for those who take the drug test at home, workplace and educational institutions.

Table of Content

Chapter 1 Preface 8
1.1 Report Description 8
1.2 Markets covered 8
1.3 Research methodology 8

Chapter 2 Executive Summary 10

Chapter 3 Drugs of Abuse Testing Market – Industry Analysis 11
3.1 Introduction 11
3.1.1 International drug trafficking 12
3.1.2 Drug trafficking and illicit drug use in North America 12
3.1.3 Drug trafficking and illicit drug use in Europe 12
3.1.4 Drug trafficking and illicit drug use in Asia-Pacific 13
3.2 Market Drivers 14
3.2.1 Globally rising consumption of illicit drugs 14
3.2.2 Adoption of drugs of abuse (DOA) testing at organizational level 15
3.2.3 Increased production of illicit drugs and their trade 16
3.2.4 Increasing death rates/road accidents due to drug abuse 17
3.3 Restraints 18
3.3.1 Social concerns associated with illicit drugs testing 18
3.3.2 Legalization of various drugs 18
3.3.3 Economic volatility and cost concerns 19

Chapter 4 Porter’s five force analysis 20
4.1 Bargaining power of buyers 20
4.2 Bargaining power of suppliers 21
4.3 Threat from new entrants 21
4.4 Intensity of rivalry 21
4.5 Threat from substitutes 21

Chapter 5 Global Drugs of Abuse Testing Market 22

Chapter 6 Drugs of Abuse Testing Market – Testing Technology Analysis 24
6.1 Immunoassay Technology 24
6.2 Chromatography Technology 25

Chapter 7 Drugs of Abuse Testing Market – Sample Analysis 27
7.1 Laboratory drug test 30
7.2 On-site screening test 31

Chapter 8 Single vs. Multiple Parameter Test 33

Chapter 9 Drugs of Abuse Market – Regional Segment Analysis 35
9.1 Scenario of drug testing in North America 35
9.1.1 Scenario of drug testing in the US 37
9.2 Scenario of drug testing in Europe 39
9.2.1 Scenario of drug testing in the UK 41
9.2.2 Scenario of drug testing in France 43
9.2.3 Scenario of drug testing in Germany 44
9.3 Scenario of drug testing in Asia-Pacific 46
9.3.1 Scenario of drug testing in India 48
9.3.2 Scenario of drug testing in China 50
9.3.3 Scenario of drug testing in Japan 52

Chapter 10 Recent Developments 54

Chapter 11 Company profiles 57
11.1 Roche Diagnostics 57
11.1.1 Overview 57
11.1.2 Products & Segments 57
11.1.3 Financial Performance 58
11.2 Quest Diagnostic 59
11.2.1 Overview 59
11.2.2 Products & Segments 59
11.2.3 Financial Performance 60
11.3 LabCorp (Laboratory Corporation of America) 61
11.3.1 Overview 61
11.3.2 Products & Segments 61
11.3.3 Financial Performance 62
11.4 Alere 63
11.4.1 Overview 63
11.4.2 Products and Segments 63
11.4.3 Financial Performance 64
11.5 Abbott Laboratories 65
11.5.1 Overview 65
11.5.2 Products & Segments 65
11.5.3 Financial Performance 66
11.6 Randox Laboratories 67
11.6.1 Overview 67
11.6.2 Products & Segments 67
11.6.3 Financial Performance 67
11.7 Psychemedics Corporation 68
11.7.1 Overview 68
11.7.2 Products & Services 68
11.7.3 Financial Performance 69
11.8 Bio-Rad Laboratories 70
11.8.1 Overview 70
11.8.2 Products & Segmentation 70
11.8.3 Financial Performance 71
11.9 Sonic Healthcare 72
11.9.1 Overview 72
11.9.2 Products & Services 72
11.9.3 Financial Performance 73
11.10 Thermo Fisher Scientific 74
11.10.1 Overview 74
11.10.2 Products & Segments 74
11.10.3 Financial performance 75

Related Reports

Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

View Full Report With Complete TOC at http://www.researchmoz.us/ophthalmic-drugs-market-dry-eye-anti-glaucoma-anti-allergyinflammatoryinfective-retinal-drugs-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2018-report.html

Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape

The approval of the DAA Sovaldi in December 2013 changed this, with a complete viral clearance being achieved in close to 100% of patients and a much improved adverse event profile compared to previous standards of therapy. In patients with genotype 2 and 3 hepatitis C, Sovaldi does not need to be administered with pegylated interferon. A number of products in the late-stage pipeline, which promise to be even more efficacious and safe are anticipated to enter the market over the forecast period, including several interferon-free therapies for genotype 1-infected patients. As a result of this, as well as an overall increase in the treated population, GBI Research believes the global market has the potential to grow to a value of $18.6 billion by 2019, more than tripling the 2012 market value of $5.8 billion.

View Full Report With Complete TOC at http://www.researchmoz.us/hepatitis-c-therapeutics-in-major-developed-markets-to-2019-outstanding-recent-approvals-and-late-stage-pipeline-to-transform-clinical-and-commercial-landscape-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry
verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our
Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep
insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Website@ http://www.researchmoz.us/
Email: sales@researchmoz.us

Advertisements

One thought on “Global Drugs of Abuse Testing Market Will Reach USD 3.4 Billion By 2018: ResearchMoz.us

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s